The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127644371 12764437 1 I 20160704 20160912 20160920 20160920 EXP US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-60283PF BOEHRINGER INGELHEIM 0.00 F Y 108.80000 KG 20160920 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127644371 12764437 1 PS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown U 21936
127644371 12764437 2 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG 0 2 MG QD
127644371 12764437 3 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG 0 2 MG QD
127644371 12764437 4 SS EYLEA AFLIBERCEPT 1 Intraocular 2 MG 0 2 MG QD
127644371 12764437 5 SS GABAPENTIN. GABAPENTIN 1 Unknown Y 0 QD
127644371 12764437 6 SS GABAPENTIN. GABAPENTIN 1 Unknown Y 0 QD
127644371 12764437 7 SS FLONASE FLUTICASONE PROPIONATE 1 Other FORMAULATION: NASAL 0
127644371 12764437 8 SS MONTELUKAST SODIUM. MONTELUKAST SODIUM 1 Unknown 10 MG 0 10 MG QD
127644371 12764437 9 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown DOSE PER APPLICATION: 160/4.5 MCG 0 BID
127644371 12764437 10 SS AZELASTINE HCL AZELASTINE HYDROCHLORIDE 1 Other FORMAULATION: NASAL 0
127644371 12764437 11 SS ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Unknown 10 MG 0 10 MG QD
127644371 12764437 12 SS ALBUTEROL. ALBUTEROL 1 Unknown FORMULATION: INHALER 0 180 UG
127644371 12764437 13 C LOSARTAN AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM 1 Unknown 0
127644371 12764437 14 C ZETIA EZETIMIBE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127644371 12764437 1 Product used for unknown indication
127644371 12764437 2 Age-related macular degeneration
127644371 12764437 5 Spinal column stenosis
127644371 12764437 7 Product used for unknown indication
127644371 12764437 8 Product used for unknown indication
127644371 12764437 9 Product used for unknown indication
127644371 12764437 10 Product used for unknown indication
127644371 12764437 11 Product used for unknown indication
127644371 12764437 12 Product used for unknown indication
127644371 12764437 13 Product used for unknown indication
127644371 12764437 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
127644371 12764437 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127644371 12764437 Asthma
127644371 12764437 Eosinophil count increased
127644371 12764437 Pulmonary function test decreased
127644371 12764437 Transient ischaemic attack

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127644371 12764437 2 20160524 0
127644371 12764437 3 20160621 20160621 0
127644371 12764437 4 20160719 20160719 0
127644371 12764437 5 201601 201602 0
127644371 12764437 6 20160703 0